Cargando…

Assessment of ESGO Quality Indicators in Cervical Cancer Surgery: A Real-World Study in a High-Volume Chinese Hospital

The ESGO developed a list of fifteen quality indicators for cervical cancer surgery in order to audit and improve clinical practice in 2020. However, data from the developing countries with high incidence rates of cervical cancer is still lacking. Therefore, we conducted a retrospective study of 708...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yan, Zhang, Xuyin, Qiu, Junjun, Zhang, Jianfeng, Hua, Keqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821940/ https://www.ncbi.nlm.nih.gov/pubmed/35145915 http://dx.doi.org/10.3389/fonc.2022.802433

Ejemplares similares

Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer
por: Ding, Yan, et al.
Publicado: (2022)

Effect of the surgical approach on survival outcomes in patients undergoing radical hysterectomy for cervical cancer: A real‐world multicenter study of a large Chinese cohort from 2006 to 2017
por: Guo, Chenyan, et al.
Publicado: (2020)

ESGO/ESTRO quality indicators for radiation therapy of cervical cancer
por: Chargari, Cyrus, et al.
Publicado: (2023)

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)
por: Kyrgiou, Maria, et al.
Publicado: (2020)

Comparison of the survival outcomes of laparoscopic, abdominal and gasless laparoscopic radical hysterectomy for early-stage cervical cancer: trial protocol of a multicenter randomized controlled trial (LAGCC trial)
por: Tang, Xiaoyan, et al.
Publicado: (2023)

An Investigation of Depressive Symptoms in Patients with Congenital Cervical and Vaginal Aplasia: A Cross-Sectional Study
por: Liu, Xiaotong, et al.
Publicado: (2022)

ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
por: Cibula, David, et al.
Publicado: (2023)

ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
por: Cibula, David, et al.
Publicado: (2023)

Comparison of oncological outcomes in elderly early-stage cervical cancer patients treated with radical surgery or radiotherapy: A real-world retrospective study with propensity score matching
por: Gu, Yu, et al.
Publicado: (2023)

Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study
por: Alejandra, Martinez, et al.
Publicado: (2021)

Ubiquitin C-terminal hydrolase L1 promotes lymph node metastasis in small cell neuroendocrine carcinomas of the cervix
por: Zhang, Yunqiang, et al.
Publicado: (2022)

Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort
por: Li, Chunbo, et al.
Publicado: (2022)

Partial Reconstruction of Uterus Cervix in Rat by Decellularized Human Uterine Cervical Scaffold Combined with Adipose-Derived Stem Cells (ADSCs)
por: Li, Yuqi, et al.
Publicado: (2022)

ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours
por: Timmerman, D, et al.
Publicado: (2021)

ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma(,)
por: Rodolakis, Alexandros, et al.
Publicado: (2023)

ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
por: Rodolakis, A, et al.
Publicado: (2023)

Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study
por: Wang, Yu-tong, et al.
Publicado: (2023)

Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World
por: Yu, Xingfei, et al.
Publicado: (2021)

Efficacy of immunotherapy in KRAS-mutant advanced NSCLC: A real-world study in a Chinese population
por: Peng, Lixiu, et al.
Publicado: (2023)

Safety and Tolerability of BRAF Inhibitor and BRAF Inhibitor-Based Combination Therapy in Chinese Patients With Advanced Melanoma: A Real World Study
por: Liu, Xing, et al.
Publicado: (2021)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up
por: Colombo, Nicoletta, et al.
Publicado: (2016)

ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors
por: Timmerman, Dirk, et al.
Publicado: (2021)

A novel Silva pattern-based model for precisely predicting recurrence in intermediate-risk cervical adenocarcinoma patients
por: Guo, Chenyan, et al.
Publicado: (2022)

New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines
por: Santoro, Angela, et al.
Publicado: (2021)

Efficacy and safety of ripretinib in Chinese patients with advanced gastrointestinal stromal tumors: a real-world, multicenter, observational study
por: Yang, Weili, et al.
Publicado: (2023)

Effectiveness and safety of anti-PD-1 monotherapy or combination therapy in Chinese advanced gastric cancer: A real-world study
por: Li, Tao, et al.
Publicado: (2023)

Characteristics, complications, and outcomes of early-stage cervical stump carcinoma: laparoscopy versus laparotomy
por: Lu, Zhiying, et al.
Publicado: (2021)

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
por: Liu, Weiping, et al.
Publicado: (2021)

Serum Circular FoxO3a Serves as a Novel Prognostic Biomarker in Squamous Cervical Cancer
por: Tang, Xiaoyan, et al.
Publicado: (2020)

Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee
por: Taumberger, Nadja, et al.
Publicado: (2022)

Chinese Expert Consensus on Iodine(125) Seed Implantation for Recurrent Cervical Cancer in 2021
por: Jiang, Ping, et al.
Publicado: (2021)

Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis
por: Pang, Xiangyi, et al.
Publicado: (2022)

The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer
por: Sun, Chang, et al.
Publicado: (2022)

A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (C-CRAL trial)
por: Qiu, Junjun, et al.
Publicado: (2023)

Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy
por: Zhang, Cui-Dai, et al.
Publicado: (2021)

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China
por: Gao, Fenghua, et al.
Publicado: (2022)

Cohort Profile: Chinese Cervical Cancer Clinical Study
por: Zhang, Xi-Ru, et al.
Publicado: (2021)

Real-World Implementation of Neurosurgical Enhanced Recovery After Surgery Protocol for Gliomas in Patients Undergoing Elective Craniotomy
por: Wang, Yuan, et al.
Publicado: (2022)

Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations
por: Shi, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2dv7msbf40eqie0hgme57nvbvc